{
    "code": "52026239",
    "url": "https:\/\/info.fda.gov.tw\/MLMS\/H0001D.aspx?Type=Lic&LicId=52026239",
    "time": "2023-07-20 21:59:55",
    "許可證字號": "衛部藥輸字第026239號",
    "註銷狀態": "",
    "註銷日期": "",
    "註銷理由": "",
    "製造許可登錄編號": "",
    "有效日期": "113\/01\/14",
    "發證\/登錄日期": "103\/01\/14",
    "許可證\/登錄種類": "製　劑",
    "舊證字號": "",
    "醫療器材級數": "",
    "第一等級醫療器材原許可證字號": "",
    "第一等級醫療器材新登錄字號": "",
    "通關簽審文件編號": "DHA05202623901",
    "中文品名": "祿荅膜衣錠50毫克",
    "英文品名": "Bicalutamide &quot;Lotus&quot; Film Coated Tablets 50mg",
    "適應症": "與LHRH類似劑療法或手術去勢療法併用於進展性攝護腺癌。",
    "劑型": "116膜衣錠",
    "包裝": "2-1000粒鋁箔盒裝",
    "儲存溫度": "",
    "有效期間": "",
    "指示藥品審查基準": "",
    "標籤、仿單及包裝加註": "",
    "藥品類別": "06須由醫師處方使用",
    "管制藥品分類級別": "",
    "藥品分類": "",
    "監視期限": "",
    "主成分略述": "BICALUTAMIDE",
    "限制項目": "02輸　入 24監視期滿學名藥",
    "申請商名稱": "美時化學製藥股份有限公司",
    "申請商地址": "台北市信義區松仁路277號17樓",
    "主製造廠": [
        {
            "製造廠名稱": "GENEPHARM S.A",
            "製造廠廠址": "18 km Marathon Avenue, 15351 Pallini-Greece\/ Greece",
            "製造廠公司地址": "",
            "製造廠國別": "GREECE",
            "製程": ""
        }
    ],
    "CCC號列": "",
    "藥理治療分類": "",
    "ingredients": [
        {
            "成分類別": "主成分",
            "成分代碼": "6808400300",
            "成分名稱": "BICALUTAMIDE",
            "含量描述": "",
            "含量": "50.0000000000",
            "單位": "MG"
        }
    ],
    "藥物辨識詳細資料": {
        "外觀尺寸": "",
        "特殊劑型": "",
        "顏色": "",
        "特殊氣味": "",
        "刻痕": "",
        "形狀": "",
        "標記一": "",
        "標記二": ""
    },
    "藥物辨識外觀圖片": [
        {
            "title": "Bicalutiide裸錠(新)-104-09-30(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026239&Seq=001&Type=10"
        }
    ],
    "仿單外盒": [
        {
            "title": "Bicalutamind_Round_2_ARTDB017685P_clear-109-05-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026239&Seq=009&Type=9"
        },
        {
            "title": "PIL-ArtworkProof_CompID_50mg_round 4-108-01-31(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026239&Seq=008&Type=9"
        },
        {
            "title": "Bicalutamide_propose PIL1031-107-11-06.pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026239&Seq=007&Type=9"
        },
        {
            "title": "Bicalutamind_Round_1_ARTDB017682F_50mg_clear-109-05-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026239&Seq=008&Type=8"
        },
        {
            "title": "Bicalutamind_Round_3_ARTDB017681C_50mg_clear-109-05-29(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026239&Seq=007&Type=8"
        },
        {
            "title": "50mg-Carton-ArtworkProof_CompID_14182_Round_1-107-08-23(廠商自行上傳).pdf",
            "url": "https:\/\/www.fda.gov.tw\/MLMS\/ShowFile.aspx?LicId=52026239&Seq=006&Type=8"
        }
    ]
}